Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines
DOSTÁLOVÁ, H.,
R. JORDA,
E. ŘEZNÍČKOVÁ,
V. KRYŠTOF
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.
Investigational New Drugs.
2023,
41(2),
210-219,
ISSN: 0167-6997,
PMID: 36913160,
PDF.
